Correlation Between Abivax SA and Maat Pharma
Can any of the company-specific risk be diversified away by investing in both Abivax SA and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abivax SA and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abivax SA and Maat Pharma SA, you can compare the effects of market volatilities on Abivax SA and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abivax SA with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abivax SA and Maat Pharma.
Diversification Opportunities for Abivax SA and Maat Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Abivax and Maat is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abivax SA and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Abivax SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abivax SA are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Abivax SA i.e., Abivax SA and Maat Pharma go up and down completely randomly.
Pair Corralation between Abivax SA and Maat Pharma
Assuming the 90 days trading horizon Abivax SA is expected to generate 2.54 times more return on investment than Maat Pharma. However, Abivax SA is 2.54 times more volatile than Maat Pharma SA. It trades about 0.22 of its potential returns per unit of risk. Maat Pharma SA is currently generating about -0.5 per unit of risk. If you would invest 594.00 in Abivax SA on November 29, 2024 and sell it today you would earn a total of 116.00 from holding Abivax SA or generate 19.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Abivax SA vs. Maat Pharma SA
Performance |
| Timeline |
| Abivax SA |
| Maat Pharma SA |
Abivax SA and Maat Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abivax SA and Maat Pharma
The main advantage of trading using opposite Abivax SA and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abivax SA position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.| Abivax SA vs. Gensight Biologics SA | Abivax SA vs. Innate Pharma | Abivax SA vs. Poxel SA | Abivax SA vs. Nanobiotix SA |
| Maat Pharma vs. OSE Pharma SA | Maat Pharma vs. Abivax SA | Maat Pharma vs. Acticor Biotech SAS | Maat Pharma vs. Waga Energy SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |